PerkinElmer Stock Soars While Molecular Devices Falls

After announcing its third-quarter results last week, PerkinElmer watched its stock jump 17 percent while Molecular Devices fell 13 percent for the five-day period ending Tuesday as the BioCommerce Week Index ended three consecutive weeks of losses.

Twelve of the 15 companies closed the week with their stock prices up over last week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.